课题基金 / 基金详情

Optimizing head and Neck Tumour And Symptom Control in Patients Unable to Tolerate Curative (Radio)Therapy: a Phase III trial Comparing Stereotactic Body Radiation Therapy (SBRT) to Standard Palliative Radiation Treatment (ON-TASC Study)

Optimizing head and Neck Tumour And Symptom Control in Patients Unable to Tolerate Curative (Radio)Therapy: a Phase III trial Comparing Stereotactic Body Radiation Therapy (SBRT) to Standard Palliative Radiation Treatment (ON-TASC Study)
优化无法耐受根治性（放射）治疗患者的头颈肿瘤和症状控制：比较立体定向全身放射治疗 (SBRT) 与标准姑息性放射治疗的 III 期试验（ON-TASC 研究）
批准号：
477985
负责人：
Parulekar Wendy R
金额：
$116.75万
依托单位：
Queen's University (Kingston, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2023
资助国家：
加拿大
项目状态：
未结题
起止时间：
2023-03-01 至 2030-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=477985&lang=en
关键词：
Head And Neck Cancer Quality Of Life Radiation Therapy Randomized Phase Iii Trial Stereotactic Body Radiation Therapy (Sbrt)

项目摘要

项目成果

Parulekar Wendy R的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Head and neck squamous cell carcinoma (HNC) that arises within the aerodigestive tract or the skin of the face/scalp affects many patients. Like most cancers, HNC incidence increases with age. Curative treatment strategies for HNC often include radiothera
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RAINBO: Refining Adjuvant treatment IN endometrial cancer Based On molecular features, TransPORTEC platform trials - The MMRD-GREEN trial
SPECT-CT Guided ELEctive Contralateral Neck Treatment (SELECT) for Patients with Lateralized Oropharyngeal Cancer: A Phase III Randomized Controlled Trial
A Phase II Single Arm Trial of Elective Volume Adjusted De-Escalation Radiotherapy (EVADER) in Patients with Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma
A Phase II Single Arm Trial of Elective Volume Adjusted De-Escalation Radiotherapy (EVADER) in Patients with Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma
海外基金